Dawkins Keith D
EVP, Global Chief Med. Off. at BSX
- Sold, on record
- $6.2M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Feb 28, 2017
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BSXBOSTON SCIENTIFIC CORPEVP, Global Chief Med. Off.
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale BSXUnusualNov 21, 2013 2013
Sold 138,850 shares at $12.00 ($1.7M)
Dawkins Keith D, EVP, Global Chief Med. Off.
Sold 62.9% of holdings ($2.6M position)81,802 shares leftFirst sale on recordFiling
- 2 Form 4 sale BSXUnusualMay 10, 2016 +901 days
Sold 80,000 shares at $22.15 ($1.8M)
Dawkins Keith D, EVP, Global Chief Med. Off.
Sold 34.7% of holdings ($5.1M position)150,227 shares leftFirst sale on recordFiling
- 3 Form 4 sale BSXUnusualFeb 7, 2017 +273 days
Sold 80,783 shares at $25.21 ($2M)
Dawkins Keith D, EVP, Global Chief Med. Off.
Sold 51.6% of holdings ($3.9M position)75,864 shares leftFiling
- 4 Form 4 sale BSXUnusualFeb 28, 2017 +21 days
Sold 30,000 shares at $24.64 ($739k)
Dawkins Keith D, EVP, Global Chief Med. Off.
Sold 30.6% of holdings ($2.4M position)68,165 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2017 | Mar 2, 2017 | BSX | EVP, Global Chief Med. Off. | Form 4 sale | 30,000 | $739k | 30.6% | Unusual | SEC |
| Feb 7, 2017 | Feb 8, 2017 | BSX | EVP, Global Chief Med. Off. | Form 4 sale | 80,783 | $2M | 51.6% | Unusual | SEC |
| May 10, 2016 | May 12, 2016 | BSX | EVP, Global Chief Med. Off. | Form 4 sale | 80,000 | $1.8M | 34.7% | Unusual | SEC |
| Nov 21, 2013 | Nov 25, 2013 | BSX | EVP, Global Chief Med. Off. | Form 4 sale | 138,850 | $1.7M | 62.9% | Unusual | SEC |